BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 29 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $108,138 | -54.2% | 327,692 | 0.0% | 0.01% | -62.5% |
| Q4 2022 | $235,938 | -40.0% | 327,692 | 0.0% | 0.02% | -57.9% |
| Q3 2022 | $393,000 | +0.8% | 327,692 | 0.0% | 0.04% | -7.3% |
| Q2 2022 | $390,000 | -24.7% | 327,692 | +36.7% | 0.04% | -38.8% |
| Q1 2022 | $518,000 | – | 239,762 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 448,101 | $537,000 | 0.11% |
| Long Focus Capital Management, LLC | 327,692 | $393,000 | 0.04% |
| Boxer Capital, LLC | 56,950 | $68,000 | 0.00% |
| SHUFRO ROSE & CO LLC | 12,941 | $16,000 | 0.00% |
| Baker Brothers Advisors | 249,123 | $299,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 45,057 | $54,000 | 0.00% |
| Orion Capital Management LLC | 500 | $1,000 | 0.00% |
| Parallel Advisors, LLC | 10 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 779 | $1,000 | 0.00% |
| NORTHERN TRUST CORP | 10,981 | $13,000 | 0.00% |